HONG KONG, Jan. 27, 2026 /PRNewswire/ -- Hong Kong's first CSI A500 Index ETF— CSOP Huatai-PineBridge CSI A500 ETF (Stock Code: 3101.HK), will list on Hong Kong Stock Exchange (HKEX) on January 28, 2026.
The listing price for 3101.HK is approximately HKD 7.9 per share, the trading lot size is 100 shares, and the annual management fee is 0.99%. The listing of CSOP Huatai-PineBridge CSI A500 ETF on HKEX marks the continued opening-up of China's financial markets and an important step in the internationalization of Chinese assets. 3101.HK is a feeder fund that, to achieve its investment objective, will invest at least 90% of its NAV in the Huatai-PineBridge CSI A500 ETF (the master fund) via the QFI status granted to CSOP Asset Management and/or the Shanghai-Hong Kong Stock Connect. The master fund was listed on Shanghai Stock Exchange in 2024 and, as of January 8, 2026, has approximately RMB 49.5 billion in assets under management, the largest among peer products globally[1].
The fund features low tracking error, high index replication, and significant scale advantages. Hong Kong investors can trade this ETF on the secondary market in HKD, with a minimum investment of about HKD 790, to capture the long-term growth opportunities of China's core assets.The CSI A500 Index (the Index) selects 500 A-share securities with relatively large market capitalization and strong liquidity from across industries as its constituents, aiming to reflect the overall performance of the most representative listed companies in each sector. From an industry allocation perspective, the CSI A500 Index has higher weights in Industrials, Information Technology, Materials, Financials, and Communication Services, which may enhance its potential to deliver relative excess returns. In 2025, CSI A500 Index achieved a return of 22.43%[2].
Mr. Zhou Yi, CEO of Huatai Securities and Chairman of China Southern Asset Management Co., Ltd. (CSAM) and CSOP Asset Management Limited (CSOP), said: "The listing of CSOP Huatai-PineBridge CSI A500 ETF in Hong Kong is an important step in CSOP's comprehensive ETF strategy. Leveraging our collaboration with Huatai-PineBridge Investments, this product provides Hong Kong investors with a new channel to invest in leading companies across China's mainstream industries, helps enrich Hong Kong's ETF market, and meets investors' demand for allocating to broad-based A-share indices."About CSOP For over a decade, CSOP has successfully established itself as one of the leading ETF issuers in Hong Kong, with the second largest AUM and demonstrated innovative product development. As of 31 December 2025, the total AUM of CSOP reached 27.4 billion USD by building a healthy ETF ecosystem and managing 64 ETPs and 4 mutual funds in Hong Kong and Singapore markets*. In 2025, 6 out of the top 10 most actively traded ETPs in Hong Kong are managed by CSOP**.*Source: CSOP
** Source: Bloomberg, from 1 January 2025 to 31 December 2025Disclaimer and Important NoticesInvestment involves risks. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and the full list of risk factors. This material is prepared by CSOP Asset Management Limited and has not been reviewed by the Securities and Futures Commission in Hong Kong. Please read the detailed disclosure and disclaimer carefully by accessing website (https://www.csopasset.com/en/education/disclaimer_en.html).
Issuer: CSOP Asset Management Limited[1] Source: Shanghai Stock Exchange
[2] Source: China Securities Index Co., Ltd.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CSOP Huatai-PineBridge CSI A500 ETF Will List on Hong Kong Stock Exchange Tomorrow
TIANJIN, China, Jan. 28, 2026 /PRNewswire/ -- The 27th China Hospital Construction Conference & International Hospital Build and Infrastructure Exposition (CHCC 2026), a globally recognized hospital construction event, will be held from May 23 to 25, 2026, at the National Convention and Exhibition Center (Tianjin), China.
Having been held successfully for 26 consecutive editions, CHCC has evolved into a widely recognized industry platform in the hospital construction sector, bringing together academic insights and industry practice. The event offers a one-stop platform for healthcare infrastructure professionals to learn, network, and explore practical solutions.
CHCC2026 will feature an exhibition spanning over 100,000 square meters, showcasing solutions from more than 800 qualified suppliers worldwide. The event is expected to attract over 60,000 professional visitors and more than 150 delegations. In parallel, the conference program will host over 100 forums with more than 1,000 speakers, drawing an anticipated audience of over 10,000 attendees.
Designed as an immersive, use-case-driven experience, CHCC 2026 is structured around eight themed pavilions, covering areas of operational efficiency, innovation in specialized medical systems, integrated building systems, interior environments, clinical space upgrades, cleanroom engineering, hospital wards, and AI technologies. Within these halls, 40 exhibition zones will cover the end-to-end hospital construction procurement process, spanning hospital planning and design, mechanical and electrical systems, interior finishing, specialized medical engineering solutions, medical equipment, medical robots, digitally enabled hospital operations, and logistics and operations management. Together, they will present thousands of integrated, application-ready solutions shaping the future of modern healthcare infrastructure.
Why Attend CHCC 2026?
1. Access complete hospital construction solutions through a one-stop platform
2. Get insights from over 1,000 experts on trends, case studies, and emerging practices in hospital construction
3. Engage in exclusive activities, including the CHCC Awards Ceremony, pre-conference training, hospital tours, book launches, and leadership talks
"This year (2025) marks our fifth year of participating in CHCC. Every exhibition has been an unforgettable experience! CHCC is a powerful platform for global business communication and growth, offering innovative solutions and unique opportunities. If you're looking to expand your influence or explore new markets, it's definitely worth a try," said Athena, President of the China German Hortig-rohrpost Group.
Held alongside the exhibition, the conference program will provide comprehensive coverage across the hospital construction process, featuring forward-looking insights and in-depth discussions across seven core areas: healthcare infrastructure, digitally enabled hospital operations, integrated medical and senior care, medical engineering, hospital facilities and logistics management, medical robotics, and clinical discipline development.
CHCC 2026 invites healthcare infrastructure professionals worldwide to visit the exhibition and join this landmark event dedicated to the planning, construction, and operation of modern healthcare facilities.
Official website: https://www.chccchina.com/en
Get your free expo ticket: https://reg.reed-sinopharm.com/pc/#/login?id=25aa73cabd5b411c9052360160ba58e3&channelUuid=dde1a7af3a0e4db68dbd6ef51c4b6a5b
Event Organizer:
CHCC2026 is jointly organized by Zhuyitai, Reed Sinopharm Exhibitions (RSE), and Z&R Exhibitions. Notably, RSE is a joint venture between Sinopharm, China's largest healthcare group, and RX Global, a world-leading event organizer.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CHCC 2026 Opens Registration, Offering a One-Stop Platform for Hospital Construction Solutions and Real-World Applications
